Medicenna Therapeutics Corp. (MDNAF)
0.66
+0.03
(+4.10%)
USD |
OTCM |
Feb 20, 16:00
Medicenna Therapeutics EPS Diluted (Quarterly) : -0.0375 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hear AtLast Holdings, Inc. | -0.0003 |
| Pharmagreen Biotech, Inc. | 0.0001 |
| CeCors, Inc. | -- |
| Venus Concept, Inc. | -12.14 |
| Achieve Life Sciences, Inc. | -0.2831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.130M |
| Total Expenses (Quarterly) | 3.130M |
| Enterprise Value | 47.41M |
| Earnings Yield | -17.05% |
| Normalized Earnings Yield | -25.98 |